FASN and breast carcinoma: Tomasz et al. described that 1,25(OH)2D3 also inhibited de novo fatty acid synthesis through down-regulation of pyruvate carboxylase, while acetyl-CoA carboxylase (ACC) and fatty acid synthase (FASN) were not altered in breast cancer cell [65].